Magnetization transfer MRI demonstrates spinal cord abnormalities in adrenomyeloneuropathy

Background: In adrenomyeloneuropathy (AMN) conventional MRI detects only spinal cord atrophy in the late stages. Objective: To apply a magnetization transfer-weighted (MTw) imaging to patients with AMN and AMN-like syndrome in order to visualize and quantitatively assess the pathology of white matter tracts in the cervical spinal cord. Methods: MTw studies were conducted in nine men with AMN, eight symptomatic heterozygous women, and 10 age- and sex-matched controls and compared to the Expanded Disability Status Scale (EDSS) and quantitative tests of vibratory sense and postural sway. MTw data sets were obtained at the level of C1 to C3 using a three-dimensional gradient echo acquisition technique, these images were then standardized between subjects by using the in-slice CSF signal as a normalization reference, allowing a quantitative assessment of the MTw signal. Results: In contrast to conventional MRI, MTw images showed signal hyperintensities in the lateral and dorsal columns of all patients. The MT signal quantified in the dorsal column showed significant differences between patients with AMN, X-linked adrenoleukodystrophy heterozygotes, and controls. MT hyperintensity in the dorsal column correlated with EDSS, vibratory sense, and postural sway. Conclusion: Magnetization transfer-weighted imaging is a sensitive modality for the visual and quantitative assessment of spinal cord pathology in adrenomyeloneuropathy, and is a potential tool for evaluation of new therapies.

[1]  Adrenoleukodystrophy: a clinical, pathological and biochemical study. , 1976, Advances in experimental medicine and biology.

[2]  W. Engel,et al.  Adrenomyeloneuropathy , 1977, Neurology.

[3]  J. Kurtzke.  Rating neurologic impairment in multiple sclerosis , 1983, Neurology.

[4]  H. Moser,et al.  Clinical aspects of adrenoleukodystrophy and adrenomyeloneuropathy. , 1991, Developmental neuroscience.

[5]  R I Grossman,et al.  Experimental allergic encephalomyelitis and multiple sclerosis: lesion characterization with magnetization transfer imaging. , 1992, Radiology.

[6]  Jean Mosser,et al.  Putative X-linked adrenoleukodystrophy gene shares unexpected homology with ABC transporters , 1993, Nature.

[7]  H. Moser,et al.  Adrenoleukodystrophy: a scoring method for brain MR observations. , 1994, AJNR. American journal of neuroradiology.

[8]  I. Faé,et al.  X-linked adrenoleukodystrophy (ALD): a novel mutation of the ALD gene in 6 members of a family presenting with 5 different phenotypes. , 1994, Biochemical and biophysical research communications.

[9]  A. J. Kumar,et al.  MR findings in adult-onset adrenoleukodystrophy. , 1995, AJNR. American journal of neuroradiology.

[10]  T.E. Prieto,et al.  Measures of postural steadiness: differences between healthy young and elderly adults , 1996, IEEE Transactions on Biomedical Engineering.

[11]  J. Mandel,et al.  Adrénoleucodystrophie liée à l'X , 2007 .

[12]  H. Moser,et al.  Improved tissue characterization in adrenoleukodystrophy using magnetization transfer imaging. , 1996, AJR. American journal of roentgenology.

[13]  A. Stillman,et al.  Proton MR spectroscopy and neuropsychological testing in adrenoleukodystrophy. , 1997, AJNR. American journal of neuroradiology.

[14]  E. Bertini,et al.  Abnormalities of somatosensory and motor evoked potentials in adrenomyeloneuropathy: Comparison with magnetic resonance imaging and clinical findings , 1997, Muscle & nerve.

[15]  Somatosensory evoked potentials in adrenomyeloneuropathy , 1997, Neurology.

[16]  H. Moser,et al.  Incidence of X-linked adrenoleukodystrophy and the relative frequency of its phenotypes. , 1998, American journal of medical genetics.

[17]  J. Frahm,et al.  Quantitative Proton Magnetic Resonance Spectroscopy of Childhood Adrenoleukodystrophy , 1998, Neuropediatrics.

[18]  H. Moser,et al.  Plasma very long chain fatty acids in 3,000 peroxisome disease patients and 29,000 controls , 1999, Annals of neurology.

[19]  R. Wanders,et al.  Progression of abnormalities in adrenomyeloneuropathy and neurologically asymptomatic X-linked adrenoleukodystrophy despite treatment with “Lorenzo’s oil” , 1999, Journal of neurology, neurosurgery, and psychiatry.

[20]  H. Moser,et al.  Accurate DNA-based diagnostic and carrier testing for X-linked adrenoleukodystrophy. , 1999, Molecular genetics and metabolism.

[21]  H. Moser,et al.  Adrenomyeloneuropathy: A Neuropathologic Review Featuring Its Noninflammatory Myelopathy , 2000, Journal of neuropathology and experimental neurology.

[22]  H. Moser,et al.  X-linked adrenoleukodystrophy: the role of contrast-enhanced MR imaging in predicting disease progression. , 2000, AJNR. American journal of neuroradiology.

[23]  H. Moser,et al.  X-Linked Adrenoleukodystrophy: Overview and Prognosis as a Function of Age and Brain Magnetic Resonance Imaging Abnormality. A Study Involving 372 Patients , 2000, Neuropediatrics.

[24]  R. Rudick,et al.  Neurological disability correlates with spinal cord axonal loss and reduced N‐acetyl aspartate in chronic multiple sclerosis patients , 2000, Annals of neurology.

[25]  H. Moser,et al.  Adrenoleukodystrophy: Incidence, new mutation rate, and results of extended family screening , 2001, Annals of neurology.

[26]  H. Moser,et al.  Evolution of phenotypes in adult male patients with X‐linked adrenoleukodystrophy , 2001, Annals of neurology.

[27]  R. Henkelman,et al.  Magnetization transfer in MRI: a review , 2001, NMR in biomedicine.

[28]  R. Ito,et al.  Diffusion tensor brain MR imaging in X-linked cerebral adrenoleukodystrophy , 2001, Neurology.

[29]  H. Moser,et al.  The Dorsal Root Ganglia in Adrenomyeloneuropathy: Neuronal Atrophy and Abnormal Mitochondria , 2001, Journal of neuropathology and experimental neurology.

[30]  M. Di Rocco,et al.  Monozygotic twins with X‐linked adrenoleukodystrophy and different phenotypes , 2001, Annals of neurology.

[31]  H. Moser,et al.  ABCD1 mutations and the X‐linked adrenoleukodystrophy mutation database: Role in diagnosis and clinical correlations , 2001, Human mutation.

[32]  H. Moser,et al.  Proton MR spectroscopic imaging predicts lesion progression on MRI in X-linked adrenoleukodystrophy , 2002, Neurology.

[33]  H. Moser,et al.  MRI and proton MRSI in women heterozygous for X-linked adrenoleukodystrophy , 2003, Neurology.

[34]  H. Moser,et al.  Analysis of MRI patterns aids prediction of progression in X-linked adrenoleukodystrophy , 2003, Neurology.

[35]  D. Hackney,et al.  Diffusion-weighted MRI and the evaluation of spinal cord axonal integrity following injury and treatment , 2003, Experimental Neurology.

[36]  W. Heiss,et al.  Spastic paraplegia associated with addison's disease: Adult variant of adreno-leukodystrophy , 2004, Journal of Neurology.

[37]  David H. Miller,et al.  Magnetization transfer ratio and myelin in postmortem multiple sclerosis brain , 2004, Annals of neurology.

[38]  Seth A. Smith,et al.  Magnetization transfer weighted imaging in the upper cervical spinal cord using cerebrospinal fluid as intersubject normalization reference (MTCSF imaging) , 2005, Magnetic resonance in medicine.

[39]  H. Moser,et al.  X-linked adrenoleukodystrophy , 1993, Clinical Neurology and Neurosurgery.

[40]  H. Moser,et al.  Very long-chain fatty acids in diagnosis, pathogenesis, and therapy of peroxisomal disorders , 2007, Lipids.